Direct inhibition of the NOTCH transcription factor complex
Open accessAbstract
Direct inhibition of transcription factor complexes remains a central challenge in the discipline of ligand discovery. In general, these proteins lack surface involutions suitable for high-affinity binding by small molecules. Here we report the design of synthetic, cell-permeable, stabilized alpha-helical peptides that target a critical protein-protein interface in the NOTCH transactivation complex. We demonstrate that direct, high-affinity binding of the hydrocarbon-stapled peptide SAHM1 prevents assembly of the active transcriptional complex. Inappropriate NOTCH activation is directly implicated in the pathogenesis of several disease states, including T-cell acute lymphoblastic leukaemia (T-ALL). The treatment of leukaemic cells with SAHM1 results in genome-wide suppression of NOTCH-activated genes. Direct antagonism of the NOTCH transcriptional program causes potent, NOTCH-specific anti-proliferative effects in cultured cells and in a mouse model of NOTCH1-driven T-ALL.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909 · see citing works
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257 · see citing works
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,706 · see citing works
Self-citationNotch signalling: a simple pathway becomes complex
Bray, S. J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2009 · Cited by 2,620 · see citing works
A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) · Nature · doi:10.1038/19083 · Cited by 2,100 · see citing works
Determination of the helix and β form of proteins in aqueous solution by circular dichroism
Chen, Y.-H., Yang, J. T., & Chau, K. H. (1974) · Biochemistry · doi:10.1021/bi00713a027 · Cited by 2,071 · see citing works
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068 · see citing works
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,691 · see citing works
Mutations in NOTCH1 cause aortic valve disease
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005) · Nature · doi:10.1038/nature03940 · Cited by 1,509 · see citing works
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349 · see citing works
Self-citationAlagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1
Li, L., Krantz, I. D., Deng, Y., Genin, A., Banta, A. B., Collins, C. C., Qi, M., Trask, B. J., Kuo, W. L., Cochran, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-243 · Cited by 1,277 · see citing works
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · see citing works
Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037 · see citing works
Self-citationNotch1 functions as a tumor suppressor in mouse skin
Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., van Noort, M., Hui, C., Clevers, H. C., Dotto, G. P., & Radtke, F. (2003) · Nature Genetics · doi:10.1038/ng1099 · Cited by 969 · see citing works
Notch signals control the fate of immature progenitor cells in the intestine
Fré, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D., & Artavanis‐Tsakonas, S. (2005) · Nature · doi:10.1038/nature03589 · Cited by 936 · see citing works
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Palomero, T., Sulis, M. L., Cortina, M. S., Real, P. J., Barnes, K., Ciofani, M., Caparrós, E., Buteau, J., Brown, K. R., Perkins, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1636 · Cited by 876 · see citing works
Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain
Dovey, H. F., John, V., Anderson, J. P., Chen, L. Z., Andrieu, P. D. S. I., Fang, L. Y., Freedman, S. B., Folmer, B., Goldbach, E. G., Holsztynska, E. J., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00012.x · Cited by 870 · see citing works
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphomaPreprint
Weng, A. P., Millholland, J. M., Yashiro–Ohtani, Y., Arcangeli, M.-L., Lau, A. N., Wai, C., Bianco, C. D., Rodríguez, C. G., Sai, H., Tobias, J. W., et al. (2006) · Genes & Development · doi:10.1101/gad.1450406 · Cited by 863 · see citing works
Self-citationPalomero, T., Lim, W. K., Odom, D. T., Sulis, M. L., Real, P. J., Margolin, A. A., Barnes, K., O’Neil, J., Neuberg, D. S., Weng, A. P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606108103 · Cited by 821 · see citing works
Self-citationPresenilin is required for activity and nuclear access of Notch in Drosophila
Struhl, G., & Greenwald, I. (1999) · Nature · doi:10.1038/19091 · Cited by 804 · see citing works
O’Neil, J., Grim, J. A., Strack, P. R., Rao, S. S., Tibbitts, D., Winter, C. G., Hardwick, J. S., Welcker, M., Meijerink, J. P. P., Pieters, R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070876 · Cited by 662 · see citing works
Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis
Miyamoto, Y., Maitra, A., Ghosh, B., Zechner, U., Argani, P., Iacobuzio-Donahue, C. A., Sriuranpong, V., Iso, T., Meszoely, I. M., Wolfe, M. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00140-5 · Cited by 643 · see citing works
Wu, L., Aster, J. C., Blacklow, S. C., Lake, R., Artavanis‐Tsakonas, S., & Griffin, J. D. (2000) · Nature Genetics · doi:10.1038/82644 · Cited by 579 · see citing works
Self-citationThe suppressor of hairless protein participates in notch receptor signaling
Fortini, M. (1994) · Cell · doi:10.1016/0092-8674(94)90196-1 · Cited by 541 · see citing works
Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants
Ye, Y., Lukinova, N. I., & Fortini, M. (1999) · Nature · doi:10.1038/19096 · Cited by 492 · see citing works
Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene
Uyttendaele, H., Marazzi, G., Wu, G., Yan, Q., Sassoon, D. A., & Kitajewski, J. (1996) · Development · doi:10.1242/dev.122.7.2251 · Cited by 485 · see citing works
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis
Pece, S., Serresi, M., Santolini, E., Capra, M. C., Hulleman, E., Galimberti, V. E., Zurrida, S., Maisonneuve, P., Viale, G., & Fiore, P. P. D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406140 · Cited by 483 · see citing works
Nam, Y., Piotr Sliz, A., Song, L., Aster, J. C., & Blacklow, S. C. (2006) · Cell · doi:10.1016/j.cell.2005.12.037 · Cited by 453 · see citing works
Self-citationγ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Real, P. J., Tosello, V., Palomero, T., Castillo-Martín, M., Hernando, E., de Stanchina, E., Sulis, M. L., Barnes, K., Sawai, C. M., Homminga, I., et al. (2008) · Nature Medicine · doi:10.1038/nm.1900 · Cited by 443 · see citing works
Riccio, O., van Gijn, M. E., Bezdek, A. C., Pellegrinet, L., van Es, J. H., Zimber‐Strobl, U., Strobl, L. J., Honjo, T., Clevers, H. C., & Radtke, F. (2008) · EMBO Reports · doi:10.1038/embor.2008.7 · Cited by 411 · see citing works
Crystal Structure of the CSL-Notch-Mastermind Ternary Complex Bound to DNA
Wilson, J. J., & Kovall, R. A. (2006) · Cell · doi:10.1016/j.cell.2006.01.035 · Cited by 371 · see citing works
Growth Suppression of Pre-T Acute Lymphoblastic Leukemia Cells by Inhibition of Notch Signaling
Weng, A. P., Nam, Y., Wolfe, M. S., Pear, W. S., Griffin, J. D., Blacklow, S. C., & Aster, J. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.655-664.2003 · Cited by 369 · see citing works
Self-citationPresenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors
Seiffert, D., Bradley, J. D., Rominger, C. M., Rominger, D. H., Yang, F., Meredith, J. E., Wang, Q., Roach, A., Thompson, L. A., Spitz, S. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005430200 · Cited by 301 · see citing works
Mastermind critically regulates Notch-mediated lymphoid cell fate decisions
Maillard, I. P., Weng, A. P., Carpenter, A. C., Rodríguez, C. G., Sai, H., Xu, L., Allman, D., Aster, J. C., & Pear, W. S. (2004) · Blood · doi:10.1182/blood-2004-02-0514 · Cited by 284 · see citing works
Self-citationAster, J. C., Xu, L., Karnell, F. G., Patriub, V., Pui, J. C., & Pear, W. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7505-7515.2000 · Cited by 278 · see citing works
Self-citationNefedova, Y., Cheng, P., Alsina, M., Dalton, W. S., & Gabrilovich, D. I. (2003) · Blood · doi:10.1182/blood-2003-07-2340 · Cited by 270 · see citing works
Notch3 Gene Amplification in Ovarian Cancer
Park, J. T., Li, M., Nakayama, K., Mao, T., Davidson, B., Zhang, Z., Kurman, R. J., Eberhart, C. G., Shih, I., & Wang, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3610 · Cited by 258 · see citing works
γ-Secretase Inhibitor Prevents Notch3 Activation and Reduces Proliferation in Human Lung Cancers
Konishi, J. S., Kawaguchi, K. S., Vo, H., Haruki, N., González, A., Carbone, D. P., & Dang, T. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1022 · Cited by 253 · see citing works
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras–initiated leukemia
Chiang, M. Y., Xu, L., Shestova, O. E., Histen, G., L’Heureux, S., Romany, C. A., Childs, M. E., Gimotty, P. A., Aster, J. C., & Pear, W. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35090 · Cited by 235 · see citing works
Self-citationWilliams, R. M., & IM, M. ‐. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00024a038 · Cited by 204 · see citing works
Nam, Y., Weng, A. P., Aster, J. C., & Blacklow, S. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301567200 · Cited by 201 · see citing works
Self-citationMastermind is a putative activator for Notch
Petcherski, A. G., & Kimble, J. E. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00577-7 · Cited by 182 · see citing works
Rao, S. S., O’Neil, J., Liberator, C. D., Hardwick, J. S., Dai, X., Zhang, T., Tyminski, E., Yuan, J., Kohl, N. E., Richon, V. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4295 · Cited by 153 · see citing works
Lewis, H. D., Leveridge, M., Strack, P. R., Haldon, C., O’Neil, J., Kim, H., Madin, A., Hannam, J. C., Look, A. T., Kohl, N. E., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.12.010 · Cited by 147 · see citing works
Stubbs, M. C., Kim, Y., Krivtsov, A., Wright, R., Feng, Z., Agarwal, J., Kung, A., & Armstrong, S. (2008) · Leukemia · doi:10.1038/sj.leu.2404951 · Cited by 128 · see citing works
Self-citationA Novel Noninvasive Model of Endometriosis for Monitoring the Efficacy of Antiangiogenic Therapy
Becker, C. M., Wright, R. D., Satchi‐Fainaro, R., Funakoshi, T., Folkman, J., Kung, A. L., & D’Amato, R. J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051133 · Cited by 84 · see citing works
Self-citationActivity of γ -Secretase on Substrates Other than APP
Alberto, D. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783334060 · Cited by 67 · see citing works
Mutational and Energetic Studies of Notch1 Transcription Complexes
Bianco, C. D., Aster, J. C., & Blacklow, S. C. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.061 · Cited by 58 · see citing works
Self-citationHallis, T. M., Kopp, A. L., Gibson, J. R., Lebakken, C. S., Hancock, M. K., VanDenHeuvel-Kramer, K., & Turek-Etienne, T. C. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107301499 · Cited by 15 · see citing works
Williams, R. M., & IM, M. ‐. (1992) · ChemInform · doi:10.1002/chin.199212255 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702 · see citing works
Transcriptional Addiction in Cancer
Bradner, J. E., Hnisz, D., & Young, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.12.013 · Cited by 1,188 · see citing works
Self-citationTargeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P., Warren, R. Q., & Ivy, S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 1,013 · see citing works
Notch Signaling in Development, Tissue Homeostasis, and Disease
Siebel, C., & Lendahl, U. (2017) · Physiological Reviews · doi:10.1152/physrev.00005.2017 · Cited by 968 · see citing works
Notch signaling: simplicity in design, versatility in function
Andersson, E. R., Sandberg, R., & Lendahl, U. (2011) · Development · doi:10.1242/dev.063610 · Cited by 950 · see citing works
Marsault, É., & Peterson, M. L. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1012374 · Cited by 862 · see citing works
Getting Across the Cell Membrane: An Overview for Small Molecules, Peptides, and Proteins
Yang, N. J., & Hinner, M. J. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2272-7_3 · Cited by 826 · see citing works
Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress
Walensky, L. D., & Bird, G. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011675 · Cited by 803 · see citing works
Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts
Stewart, M. P., Langer, R., & Jensen, K. F. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00678 · Cited by 748 · see citing works
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727 · see citing works
Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412070 · Cited by 718 · see citing works
Therapeutic antibody targeting of individual Notch receptors
Wu, Y., Cain-Hom, C., Choy, L., Hagenbeek, T. J., de Leon, G. P., Chen, Y., Finkle, D., Venook, R., Wu, X., Ridgway, J. B., et al. (2010) · Nature · doi:10.1038/nature08878 · Cited by 713 · see citing works
Mesoporous silica nanoparticles in medicine—Recent advances
Mamaeva, V., Sahlgren, C., & Lindén, M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.018 · Cited by 709 · see citing works
Notch Signaling in the Tumor Microenvironment
Meurette, O., & Mehlen, P. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.009 · Cited by 680 · see citing works
Chang, Y. S., Graves, B. J., Guerlavais, V., Tovar, C., Packman, K. E., To, K.-H., Olson, K. A., Kesavan, K. P., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 666 · see citing works
Notch Signaling in the Immune System
Radtke, F., Fasnacht, N., & MacDonald, H. R. (2010) · Immunity · doi:10.1016/j.immuni.2010.01.004 · Cited by 546 · see citing works
Overcoming therapeutic resistance in glioblastoma: the way forward
Osuka, S., & Meir, E. G. V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci89587 · Cited by 509 · see citing works
Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497 · see citing works
The molecular basis of T cell acute lymphoblastic leukemia
Vlierberghe, P. V., & Ferrando, A. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61269 · Cited by 489 · see citing works
Therapeutic modulation of Notch signalling — are we there yet?
Andersson, E. R., & Lendahl, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4252 · Cited by 452 · see citing works
Targeting Notch to Target Cancer Stem Cells
Pannuti, A., Foreman, K. E., Rizzo, P., Osipo, C., Golde, T. E., Osborne, B. A., & Miele, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2823 · Cited by 452 · see citing works
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
Shi, Q., Xue, C., Zeng, Y., Yuan, X., Chu, Q., Jiang, S., Wang, J., Zhang, Y., Zhu, D., & Li, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01828-x · Cited by 428 · see citing works
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 418 · see citing works
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Takebe, N., Nguyen, D., & Yang, S. X. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.005 · Cited by 416 · see citing works
Targeting protein–protein interactions as an anticancer strategy
Ivanov, A. A., Khuri, F. R., & Fu, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.007 · Cited by 401 · see citing works
Stapled Peptides for Intracellular Drug Targets
Verdine, G. L., & Hilinski, G. J. (2012) · Methods in Enzymology · doi:10.1016/b978-0-12-396962-0.00001-x · Cited by 433 · see citing works
Self-citationGuo, Z., Mohanty, U., Noehre, J., Sawyer, T. K., Sherman, W., & Krilov, G. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.00951.x · Cited by 385 · see citing works
New Modalities for Challenging Targets in Drug Discovery
Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611914 · Cited by 382 · see citing works
Translating p53 into the clinic
Cheok, C. F., Verma, C. S., Baselga, J., & Lane, D. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.174 · Cited by 381 · see citing works
Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin metathesis
Kim, Y.-W., Grossmann, T. N., & Verdine, G. L. (2011) · Nature Protocols · doi:10.1038/nprot.2011.324 · Cited by 376 · see citing works
Self-citationFrom Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Ntziachristos, P., Lim, J. S., Sage, J., & Aifantis, I. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.018 · Cited by 369 · see citing works
The genetics and molecular biology of T-ALL
Girardi, T., Vicente, C., Cools, J., & Keersmaecker, K. D. (2017) · Blood · doi:10.1182/blood-2016-10-706465 · Cited by 355 · see citing works
Peptide therapeutics: Targeting the undruggable space
Tsomaia, N. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.014 · Cited by 348 · see citing works
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
Kim, W., Bird, G. H., Neff, T., Guo, G., Kerényi, M., Walensky, L., & Orkin, S. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1331 · Cited by 357 · see citing works
Therapeutic strategies targeting FOXO transcription factors
Calissi, G., Lam, E. W. ‐., & Link, W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0088-2 · Cited by 336 · see citing works
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
Kridel, R., Meissner, B., Rogić, S., Boyle, M., Telenius, A., Woolcock, B. W., Gunawardana, J., Jenkins, C. R., Cochrane, C., Ben‐Neriah, S., et al. (2011) · Blood · doi:10.1182/blood-2011-11-391474 · Cited by 335 · see citing works
The switch from fetal to adult hemoglobin.
Sankaran, V. G., & Orkin, S. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011643 · Cited by 333 · see citing works
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
Chi, P., Chen, Y., Zhang, L., Guo, X., Wongvipat, J., Shamu, T., Fletcher, J. A., Dewell, S. B., Maki, R. G., Zheng, D., et al. (2010) · Nature · doi:10.1038/nature09409 · Cited by 333 · see citing works
Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326 · see citing works
Tschaharganeh, D. F., Chen, X., Latzko, P., Malz, M., Gaida, M. M., Felix, K., Ladu, S., Singer, S., Pinna, F., Gretz, N., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.009 · Cited by 326 · see citing works
Notch Signaling and the Skeleton.
Zanotti, S., & Canalis, E. (2016) · Endocrine reviews · doi:10.1210/er.2016-1002 · Cited by 283 · see citing works
RNA Display Methods for the Discovery of Bioactive Macrocycles
Huang, Y., Wiedmann, M. M., & Suga, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00430 · Cited by 309 · see citing works
Assessing Helical Protein Interfaces for Inhibitor Design
Bullock, B. N., Jochim, A. L., & Arora, P. S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206074j · Cited by 298 · see citing works
Stapled Helical Peptides Bearing Different Anchoring Residues
Li, X., Chen, S., Zhang, W., & Hu, H. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00532 · Cited by 296 · see citing works
An orthosteric inhibitor of the Ras-Sos interaction
Patgiri, A., Yadav, K. K., Arora, P. S., & Bar‐Sagi, D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.612 · Cited by 294 · see citing works
Modulating protein–protein interactions: the potential of peptides
Nevola, L., & Giralt, E. (2014) · Chemical Communications · doi:10.1039/c4cc08565e · Cited by 291 · see citing works
Hydrocarbon Stapled Peptides as Modulators of Biological Function
Cromm, P. M., Spiegel, J., & Grossmann, T. N. (2015) · ACS Chemical Biology · doi:10.1021/cb501020r · Cited by 289 · see citing works
Tissue macrophage identity and self‐renewal
Gentek, R., Molawi, K., & Sieweke, M. H. (2014) · Immunological Reviews · doi:10.1111/imr.12224 · Cited by 277 · see citing works
Targeting Transcription Factors in Cancer
Bhagwat, A. S., & Vakoc, C. R. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.07.001 · Cited by 276 · see citing works
Targeting Notch in oncology: the path forward
Majumder, S., Crabtree, J. S., Golde, T. E., Minter, L. M., Osborne, B. A., & Miele, L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00091-3 · Cited by 274 · see citing works
Notch inhibitors for cancer treatment
Espinoza, I. C., & Miele, L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.003 · Cited by 272 · see citing works
Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin
Grossmann, T. N., Yeh, J. T.-H., Bowman, B. R., Chu, Q., Moellering, R. E., & Verdine, G. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208396109 · Cited by 268 · see citing works
Self-citationInterfacial inhibitors: targeting macromolecular complexes
Pommier, Y. G., & Marchand, C. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3404 · Cited by 260 · see citing works
Emerging roles of TEAD transcription factors and its coactivators in cancers
Pobbati, A. V., & Hong, W. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23788 · Cited by 256 · see citing works
Systems approaches to polypharmacology and drug discovery.
Boran, A. D. W., & Iyengar, R. (2010) · PubMed · Cited by 253 · see citing works
Kawamoto, S. A., Coleska, A., Xu, R., Han, Y., Yang, C., & Wang, S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201125d · Cited by 252 · see citing works
The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia
Sánchez-Martín, M., & Ferrando, A. A. (2017) · Blood · doi:10.1182/blood-2016-09-692582 · Cited by 252 · see citing works
Design and Structure of Stapled Peptides Binding to Estrogen Receptors
Phillips, C., Roberts, L. R., Schade, M., Bazin, R., Bent, A., Davies, N. L., Moore, R., Pannifer, A. D., Pickford, A. R., Prior, S. H., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202946k · Cited by 247 · see citing works
p53-based Cancer TherapyPreprint
Lane, D. P., Cheok, C. F., & Laı́n, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001222 · Cited by 244 · see citing works
Evolving the use of peptides as components of biomaterials
Collier, J. H., & Segura, T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.030 · Cited by 242 · see citing works
In Vitro Selection of Highly Modified Cyclic Peptides That Act as Tight Binding Inhibitors
Schlippe, Y. V. G., Hartman, M. C. T., Josephson, K., & Szostak, J. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301017y · Cited by 241 · see citing works
Notch: The Past, the Present, and the Future
Artavanis‐Tsakonas, S., & Muskavitch, M. A. T. (2010) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92001-2 · Cited by 240 · see citing works
GSEA-InContext: identifying novel and common patterns in expression experiments
Powers, R. K., Goodspeed, A., Pielke-Lombardo, H., Tan, A. C., & Costello, J. C. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty271 · Cited by 240 · see citing works
What makes a good drug target?
Gashaw, I., Ellinghaus, P., Sommer, A., & Asadullah, K. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.007 · Cited by 238 · see citing works
Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability
Surade, S., & Blundell, T. L. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.013 · Cited by 230 · see citing works
Liu, M., Li, C., Pazgier, M., Li, C., Mao, Y., Lv, Y., Gu, B., Wei, G., Yuan, W., Zhan, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008930107 · Cited by 229 · see citing works
Therapeutic Strategies to Inhibit MYCPreprint
McKeown, M. R., & Bradner, J. E. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014266 · Cited by 226 · see citing works
Self-citationBock, J. E., Gavenonis, J., & Kritzer, J. A. (2012) · ACS Chemical Biology · doi:10.1021/cb300515u · Cited by 222 · see citing works
Mamaeva, V., Rosenholm, J. M., Bate-Eya, L. T., Bergman, L., Peuhu, E., Duchanoy, A., Fortelius, L. E., Landor, S. K.-J., Toivola, D. M., Lindén, M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.105 · Cited by 220 · see citing works
Towards understanding cell penetration by stapled peptides
Chu, Q., Moellering, R. E., Hilinski, G. J., Kim, Y., Grossmann, T. N., Yeh, J. T. ‐., & Verdine, G. L. (2014) · MedChemComm · doi:10.1039/c4md00131a · Cited by 219 · see citing works
Self-citationDifferentiation of NUT Midline Carcinoma by Epigenomic Reprogramming
Schwartz, B. E., Hofer, M. D., Lemieux, M. E., Bauer, D. E., Cameron, M. J., West, N. H., Agoston, E. S., Reynoird, N., Khochbin, S., Ince, T. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3513 · Cited by 216 · see citing works
Self-citationFunctionalised staple linkages for modulating the cellular activity of stapled peptides
Lau, Y. H., de Andrade, P., Quah, S. T., Rossmann, M., Laraia, L., Sköld, N., Sum, T. J., Rowling, P. J. E., Joseph, T. L., Verma, C. S., et al. (2014) · Chemical Science · doi:10.1039/c4sc00045e · Cited by 215 · see citing works
Cell-Permeable Cyclic Peptides from Synthetic Libraries Inspired by Natural Products
Hewitt, W. M., Leung, S. S. F., Pye, C. R., Ponkey, A. R., Bednarek, M. A., Jacobson, M. P., & Lokey, R. S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508766b · Cited by 214 · see citing works
Mechanistic Insights into Notch Receptor Signaling from Structural and Biochemical Studies
Kovall, R. A., & Blacklow, S. C. (2010) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92002-4 · Cited by 213 · see citing works
Self-citationHodson, D. J., Janas, M. L., Galloway, A., Bell, S. E., Andrews, S., Li, C. M., Pannell, R., Siebel, C. W., MacDonald, H. R., Keersmaecker, K. D., et al. (2010) · Nature Immunology · doi:10.1038/ni.1901 · Cited by 212 · see citing works
Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner
Pajvani, U. B., Shawber, C. J., Samuel, V. T., Birkenfeld, A. L., Shulman, G. I., Kitajewski, J., & Accili, D. (2011) · Nature Medicine · doi:10.1038/nm.2378 · Cited by 203 · see citing works
Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics
Ding, Y., Ting, J. P., Liu, J., Al-Azzam, S., Pandya, P., & Afshar, S. (2020) · Amino Acids · doi:10.1007/s00726-020-02890-9 · Cited by 200 · see citing works
Protein-protein interaction modulators: advances, successes and remaining challenges
Mabonga, L., & Kappo, A. P. (2019) · Biophysical Reviews · doi:10.1007/s12551-019-00570-x · Cited by 196 · see citing works
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes
Choi, S. H., Gearhart, M. D., Cui, Z., Bosnakovski, D., Kim, M., Schennum, N., & Kyba, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw141 · Cited by 196 · see citing works
Targeting Protein-Protein Interaction by Small Molecules
Jin, L., Wang, W., & Fang, G. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140028 · Cited by 195 · see citing works
Precision medicine for human cancers with Notch signaling dysregulation (Review)
Katoh, M., & Katoh, M. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4418 · Cited by 196 · see citing works
Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy
Borah, A., Raveendran, S., Rochani, A., Maekawa, T., & Kumar, D. S. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.35 · Cited by 192 · see citing works
Systematic Analysis of Helical Protein Interfaces Reveals Targets for Synthetic Inhibitors
Jochim, A. L., & Arora, P. S. (2010) · ACS Chemical Biology · doi:10.1021/cb1001747 · Cited by 191 · see citing works
A complex task? Direct modulation of transcription factors with small molecules
Koehler, A. N. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.022 · Cited by 189 · see citing works
A Thiol–Ene Coupling Approach to Native Peptide Stapling and Macrocyclization
Wang, Y., & Chou, D. H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201503975 · Cited by 187 · see citing works
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
Miele, L., Espinoza, I. C., Pochampally, Watabe, & Xing, F. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36162 · Cited by 185 · see citing works
Hales, E. C., Taub, J. W., & Matherly, L. H. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.021 · Cited by 183 · see citing works
How Chemoproteomics Can Enable Drug Discovery and Development
Moellering, R. E., & Cravatt, B. F. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.001 · Cited by 182 · see citing works
Self-citationStructural biology and drug discovery for protein–protein interactions
Jubb, H. C., Higueruelo, A. P., Winter, A., & Blundell, T. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.006 · Cited by 182 · see citing works
Ahlbach, C., Lexa, K. W., Bockus, A. T., Chen, V., Crews, P., Jacobson, M. P., & Lokey, R. S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.78 · Cited by 179 · see citing works
Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders
Bauer, D. E., Kamran, S. C., & Orkin, S. H. (2012) · Blood · doi:10.1182/blood-2012-06-292078 · Cited by 177 · see citing works
Comparative α‐Helicity of Cyclic Pentapeptides in Water
de Araujo, A. D., Hoang, H. N., Kok, W. M., Diness, F., Gupta, P. K., Hill, T. A., Driver, R. W., Price, D. A., Liras, S. I., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310245 · Cited by 177 · see citing works
Notch signaling: Emerging molecular targets for cancer therapy
Yin, L., Velazquez, O. C., & Liu, Z. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.026 · Cited by 177 · see citing works
Stapled Peptides Inhibitors: A New Window for Target Drug Discovery
Ali, A. M., Atmaj, J., Oosterwijk, N. V., Groves, M. R., & Dömling, A. S. S. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.01.012 · Cited by 177 · see citing works
The N otch pathway in colorectal cancer
Vinson, K. E., George, D. C., Fender, A. W., Bertrand, F. E., & Sigounas, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29800 · Cited by 175 · see citing works
Expanding the Number of ‘Druggable’ Targets: Non‐Enzymes and Protein–Protein Interactions
Makley, L. N., & Gestwicki, J. E. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12066 · Cited by 175 · see citing works
The Notch signaling pathway: a potential target for cancer immunotherapy
Li, X., Yan, X., Wang, Y., Kaur, B., Han, H., & Yu, J. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01439-z · Cited by 174 · see citing works
Previs, R. A., Coleman, R. L., Harris, A. L., & Sood, A. K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0809 · Cited by 173 · see citing works
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination
Wegener, A., Deboux, C., Bachelin, C., Frah, M., Kerninon, C., Seilhean, D., Weider, M., Wegner, M., & Nait‐Oumesmar, B. (2014) · Brain · doi:10.1093/brain/awu375 · Cited by 169 · see citing works
Computational design of peptide ligands
Vanhee, P., van der Sloot, A. M., Verschueren, E., Serrano, L. G., Rousseau, F., & Schymkowitz, J. W. H. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.01.004 · Cited by 167 · see citing works
- Authors
- Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E.
- Affiliations
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Dana-Farber Cancer Institute (US)
- Harvard University (US)
- Corresponding author
- Verdine, Gregory L.
- Bradner, James E.
- ORCID
- Venue
- Nature
- Published
- 2009-11-12
- Volume
- 462
- Issue
- 7270
- Pages
- 182-188
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2951323
- OpenAlex
- W2085948054
- Cited by
- 752
- References
- 51
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 12 · 2023: 30 · 2022: 21 · 2021: 28 · 2020: 43 · 2019: 35 · 2018: 47 · 2017: 43 · 2016: 34 · 2015: 56 · 2014: 70 · 2013: 76 · 2012: 75
- FWCI
- 32.31
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-01-21)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Funders
- National Institutes of Health (n01co12400-79-0-22, 5t32gm007598-41)
- National Cancer Institute (N01CO12400, N01-CO-012400, P01CA119070, R01CA092433, R56CA092433)
- National Institute of General Medical Sciences (5T32GM007598, T32-GM007598)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- Notch signaling, hydrocarbon-stapled peptides, protein-protein interaction inhibition, T-cell acute lymphoblastic leukemia, Notch1, transcription factor antagonism, cell-permeable peptide
- MeSH terms
- Animals, Binding, Competitive, Cell Membrane Permeability, Disease Models, Animal, DNA-Binding Proteins, Humans, Models, Molecular, Nuclear Proteins, Peptides, Protein Binding, Substrate Specificity, Transcription Factors, Signal Transduction, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Genome, Protein Structure, Secondary, Protein Structure, Tertiary, Drosophila Proteins, Cell Line, Tumor, Cell Proliferation, Mice, Immunoglobulin J Recombination Signal Sequence-Binding Protein, Receptor, Notch1, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review